A major unmet need is the lack of high-fidelity tools to focus the right treatments on the right patients. In oncology, treatments are personalized based on genetic and protein biomarkers whereas metabolic syndrome patients are being prescribed drugs based on their blood pressure, fasting glucose and cholesterol levels. As metabolic syndrome is a complex multifactorial condition, it requires systems medicine models and composite biomarkers that were hitherto infeasible. ML-enabled data science and rapidly-falling omics costs have changed the game and we are aiming at becoming the leader in this space.

MultiOmic Health

MultiOmic Health